<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>TCGA Cancer Effect Size Track Hub</title>
</head>
<body>
  <h2>TCGA Cancer Effect Size Track Hub</h2>
  <p>
    Cancer effect size quantifies natural selection on somatic mutations across <strong>20 TCGA cancer cohorts</strong>. 
    Each track displays Cancer Effect Size (CES) values from <strong>cancereffectsizeR</strong> - how much each mutation 
    contributes to cancer cell proliferation in specific tumor types.
  </p>

  <h3>20 TCGA Cancer Cohorts</h3>
  <table style="border-collapse: collapse; border: 1px solid #ccc;">
    <tr><th>TCGA Code</th><th>Cancer Type</th><th>Full Name</th></tr>
    <tr><td>BLCA</td><td>Bladder</td><td>Bladder Urothelial Carcinoma</td></tr>
    <tr><td>BRCA</td><td>Breast</td><td>Breast Invasive Carcinoma</td></tr>
    <tr><td>CESC</td><td>Cervical</td><td>Cervical Squamous Cell Carcinoma</td></tr>
    <tr><td>COAD</td><td>Colon</td><td>Colon Adenocarcinoma</td></tr>
    <tr><td>ESCA</td><td>Esophageal</td><td>Esophageal Carcinoma</td></tr>
    <tr><td>GBM</td><td>Glioblastoma</td><td>Glioblastoma Multiforme</td></tr>
    <tr><td>HNSC</td><td>Head & Neck</td><td>Head and Neck Squamous Cell Carcinoma</td></tr>
    <tr><td>KIRC</td><td>Kidney</td><td>Kidney Renal Clear Cell Carcinoma</td></tr>
    <tr><td>LGG</td><td>Brain</td><td>Brain Lower Grade Glioma</td></tr>
    <tr><td>LIHC</td><td>Liver</td><td>Liver Hepatocellular Carcinoma</td></tr>
    <tr><td>LUAD</td><td>Lung Adeno</td><td>Lung Adenocarcinoma</td></tr>
    <tr><td>LUSC</td><td>Lung Squamous</td><td>Lung Squamous Cell Carcinoma</td></tr>
    <tr><td>DLBC</td><td>Lymphoma</td><td>Lymphoid Neoplasm Diffuse Large B-cell Lymphoma</td></tr>
    <tr><td>OV</td><td>Ovarian</td><td>Ovarian Serous Cystadenocarcinoma</td></tr>
    <tr><td>PAAD</td><td>Pancreas</td><td>Pancreatic Adenocarcinoma</td></tr>
    <tr><td>PRAD</td><td>Prostate</td><td>Prostate Adenocarcinoma</td></tr>
    <tr><td>READ</td><td>Rectum</td><td>Rectum Adenocarcinoma</td></tr>
    <tr><td>SKCM</td><td>Melanoma</td><td>Skin Cutaneous Melanoma</td></tr>
    <tr><td>STAD</td><td>Stomach</td><td>Stomach Adenocarcinoma</td></tr>
    <tr><td>THCA</td><td>Thyroid</td><td>Thyroid Carcinoma</td></tr>
    <tr><td>UCEC</td><td>Uterine</td><td>Uterine Corpus Endometrial Carcinoma</td></tr>
  </table>

  <h3>Display Conventions</h3>
  <p>Each subtrack shows CES scores transformed via <em>f(x) = (10 Â· log(x)) - 10</em>:
    <ul>
      <li><strong>Positive score</strong> = Positive selection</li>
      <li><strong>Score = 1</strong> = Neutral selection</li>
      <li><strong>Score = 0</strong> = Negative selection</li>
    </ul>
    Reverse: <em>10<sup>((y+10)/10)</sup></em>
  </p>
  <p>Search by <strong>gene_variant</strong> names (e.g., <code>KIF1B_R1320W</code>) in UCSC search box.</p>

  <h3>Methods</h3>
  <p>CES calculated by cancereffectsizeR: estimates neutral mutation rate per site using tissue-specific 
  gene mutation rates + mutational signatures, then compares to observed rates [web:36].</p>

  <h3>Contact</h3>
  <p>Prarthana Sanjeeva Reddy (Townsend Lab, Yale)<br>
  PI: Dr. Jeffrey Townsend <a href="mailto:jeffrey.townsend@yale.edu">jeffrey.townsend@yale.edu</a></p>

  <h3>Reference</h3>
  <p>Mandell JD, et al. <em>Cancer Research</em> 2023. 
  <a href="https://doi.org/10.1158/0008-5472.CAN-22-1508">doi:10.1158/0008-5472.CAN-22-1508</a></p>
</body>
</html>
